Trial intelligence / Profile preview

N-acetylcysteine to Reduce Ischemia/Reperfusion Injury in Liver Resection

NCT01223326Phase 4Completed

Sponsor
Universidad de Navarra
Start
Jan 2003
Primary completion
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of acetylcysteine in reperfusion injury (IRI), sponsored by Universidad de Navarra. Started Jan 2003; status: completed.

02

Drugs

acetylcysteine
03

Conditions

reperfusion injury (IRI)

Beyond the preview

Go deeper on NCT01223326.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01223326.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call